Filing Details
- Accession Number:
- 0001839882-22-022698
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-10-03 16:35:12
- Reporting Period:
- 2022-09-30
- Accepted Time:
- 2022-10-03 16:35:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1625101 | Pulse Biosciences Inc. | PLSE | Surgical & Medical Instruments & Apparatus (3841) | 465696597 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1913245 | Patrick Kevin Danahy | C/O Pulse Biosciences, Inc. 3957 Point Eden Way Hayward CA 94545 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-30 | 6,500 | $2.30 | 6,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This purchase price represents the weighted average purchase price of the shares purchased on September 30, 2022, ranging from $2.28 to $2.31 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
Billionaire Hedge Funds
